These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 16162433)

  • 1. Clinical experience with levetiracetam in idiopathic generalized epilepsy according to different syndrome subtypes.
    Di Bonaventura C; Fattouch J; Mari F; Egeo G; Vaudano AE; Prencipe M; Manfredi M; Giallonardo AT
    Epileptic Disord; 2005 Sep; 7(3):231-5. PubMed ID: 16162433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open label, long-term, pragmatic study on levetiracetam in the treatment of juvenile myoclonic epilepsy.
    Specchio LM; Gambardella A; Giallonardo AT; Michelucci R; Specchio N; Boero G; La Neve A
    Epilepsy Res; 2006 Sep; 71(1):32-9. PubMed ID: 16814521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsy.
    Specchio N; Boero G; Michelucci R; Gambardella A; Giallonardo AT; Fattouch J; Di Bonaventura C; de Palo A; Ladogana M; Lamberti P; Vigevano F; La Neve A; Specchio LM
    Epilepsia; 2008 Apr; 49(4):663-9. PubMed ID: 18266754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
    Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E
    Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents.
    Verrotti A; Cerminara C; Coppola G; Franzoni E; Parisi P; Iannetti P; Aloisi P; Tozzi E; Cusmai R; Vigevano F; Chiarelli F; Curatolo P
    Dev Med Child Neurol; 2008 Jan; 50(1):29-32. PubMed ID: 18173626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam in absence epilepsy.
    Verrotti A; Cerminara C; Domizio S; Mohn A; Franzoni E; Coppola G; Zamponi N; Parisi P; Iannetti P; Curatolo P
    Dev Med Child Neurol; 2008 Nov; 50(11):850-3. PubMed ID: 18808424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study.
    Gericke CA; Picard F; de Saint-Martin A; Strumia S; Marescaux C; Hirsch E
    Epileptic Disord; 1999 Sep; 1(3):159-65. PubMed ID: 10937148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eyelid myoclonia with absences occurring during the clinical course of cryptogenic myoclonic epilepsy of early childhood.
    Ohya T; Yamashita Y; Shibuya I; Hara M; Nagamitsu S; Matsuishi T
    Eur J Paediatr Neurol; 2012 Jul; 16(4):399-401. PubMed ID: 22153876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam: preliminary efficacy in generalized seizures.
    Kasteleijn-Nolst Trenité DG; Hirsch E
    Epileptic Disord; 2003 May; 5 Suppl 1():S39-44. PubMed ID: 12915340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggravation of absence seizure related to levetiracetam.
    Auvin S; Chhun S; Berquin P; Ponchel E; Delanoë C; Chiron C
    Eur J Paediatr Neurol; 2011 Nov; 15(6):508-11. PubMed ID: 21680209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam monotherapy in children with epilepsy.
    Khurana DS; Kothare SV; Valencia I; Melvin JJ; Legido A
    Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complex therapy of idiopathic forms of epilepsy with small doses of valproates and levetiracetam].
    Karlov VA; Freĭdkova NV; Rusanova LV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(6 Pt 2):37-9. PubMed ID: 22983238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid effect of levetiracetam in a case of juvenile myoclonic epilepsy.
    Belcastro V; Costa C; Galletti F; Rossi A; Tambasco N; Striano P
    Epilepsy Behav; 2009 Jan; 14(1):269-70. PubMed ID: 18804185
    [No Abstract]   [Full Text] [Related]  

  • 16. [Idiopathic absence epilepsy].
    Szczepanik E; Pakszys M
    Przegl Lek; 2001; 58 Suppl 1():32-6. PubMed ID: 11355107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?
    Montouris G; Abou-Khalil B
    Epilepsia; 2009 Sep; 50 Suppl 8():16-20. PubMed ID: 19702728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of levetiracetam in treating epilepsy associated with other medical conditions.
    Di Bonaventura C; Mari F; Fattouch J; Egeo G; Vaudano AE; Manfredi M; Prencipe M; Giallonardo AT
    Acta Neurol Scand; 2006 Feb; 113(2):82-6. PubMed ID: 16411967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of zonisamide on the electroencephalogram of a patient with juvenile myoclonic epilepsy.
    Szaflarski JP
    Epilepsy Behav; 2004 Dec; 5(6):1024-6. PubMed ID: 15582856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levetiracetam in the treatment of Lennox-Gastaut syndrome.
    De Los Reyes EC; Sharp GB; Williams JP; Hale SE
    Pediatr Neurol; 2004 Apr; 30(4):254-6. PubMed ID: 15087103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.